Homocysteine, B vitamins, and coronary artery disease

Medical Clinics of North America

Volumn 84, Issue 1, 2000, Pages 215-237

  Seshadri, Niranjan ^a   Robinson, Killian ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; VITAMIN B GROUP;

CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK BENEFIT ANALYSIS; VITAMIN SUPPLEMENTATION;

EID: 0033967795     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70215-7     Document Type: Article

References (134)

1. G. Alfthan J. Pekkanen M. Jauhiainen Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study Atherosclerosis 106 1994 9 19
2. A. Araki Y. Sako H. Ito Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: Effect of parenteral methylcobalamin treatment Atherosclerosis 103 1993 149 157
3. M. Arnadottir B. Hultberg V. Vladov Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients Transplantation 61 1996 509 512
4. E. Arnesen H. Refsum K.H. Bonaa Serum total homocysteine and coronary heart disease Int J Epidemiol 24 1995 704 709
5. T.K. Basu S. Mann Vitamin B-6 normalizes the altered sulfur amino acid status of rats fed diets containing pharmacological levels of niacin without reducing niacin's hypolipidemic effects J Nutr 127 1997 117 121
6. K. Bhagat P. Vallance Nitric oxide 9 years on J R Soc Med 89 1996 667 673
7. T. Bienvenu A. Ankri B. Chadefaux [Plasma homocysteine assay in the exploration of thrombosis in young subjects] Presse Med 20 1991 985 988
8. D. Blankenhorn R. Malinow W. Mack Colestipol plus niacin therapy elevates plasma homocyst(e)ine levels Coron Artery Dis 2 1991 357 360
9. G.H. Boers A.G. Smals F.J. Trijbels Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease N Engl J Med 313 1985 709 715
10. A.G. Bostom R.Y. Gohh M.Y. Tsai Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients Arterioscler Thromb Biol 17 1997 1894 1900
11. A.G. Bostom L. Lathrop Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes Kidney Int 52 1997 10 20
12. A.G. Bostom D. Shemin K.L. Lapane High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients Kidney Int 49 1996 147 152
13. A.G. Bostom H. Silbershatz I.H. Rosenberg Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women Arch Intern Med 159 1999 1077 1080
14. M.L. Bots L.J. Launer J. Lindemans Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: The Rotterdam Study Arch Intern Med 159 1999 38 44
15. C.J. Boushey S.A. Beresford G.S. Omenn A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes [see comments] JAMA 274 1995 1049 1057
16. L. Brattström B. Israelsson B. Norrving Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease: Effects of pyridoxine and folic acid treatment Atherosclerosis 81 1990 51 60
17. L. Brattström B. Israelsson L. Tengborn Homocysteine, factor VII and antithrombin III in subjects with different gene dosage for cystathionine beta-synthase J Inherit Metab Dis 12 1989 475 482
18. L. Brattström L. Tengborn C. Lagerstedt Plasma homocysteine in venous thromboembolism Haemostasis 21 1991 51 57
19. L. Brattström D. Wilcken J. Öhrvick Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The results of a meta-analysis Circulation 98 1998 2520 2526
20. S.M. Carlsen I. Folling V. Grill Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease Scand J Clin Lab Invest 57 1997 521 527
21. N.A.J. Carson D.W. Neill Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland Arch Dis Child 37 1962 505 513
22. M. Cattaneo L. Baglietto M.L. Zighetti Tamoxifen reduces plasma homocysteine levels in healthy women Br J Cancer 77 1998 2264 2266
23. M. Cattaneo M. Vecchi M. Zighetti High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease Neth Med J 52 1998 S35
24. J.C. Chambers A. McGregor J. Jean-Marie Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: An effect reversible with vitamin C therapy Circulation 99 1999 1156 1160
25. L. Chasan-Taber J. Selhub I.H. Rosenberg A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians J Am Coll Nutr 15 1996 136 143
26. P. Chauveau B. Chadefaux M. Coude Increased plasma homocysteine concentration in patients with chronic renal failure Miner Electrolyte Metab 18 1992 196 198
27. P. Chen R. Poddar E. Tipa Homocysteine metabolism in cardiovascular cells and tissues: Implications for hyperhomocysteinemia and cardiovascular disease Adv Enzyme Regul 39 1999 93 109
28. R. Clarke L. Daly K. Robinson Hyperhomocysteinemia: An independent risk factor for vascular disease N Engl J Med 324 1991 1149 1155
29. B.D. Cohen H. Patel R.S. Kornhauser Alternate reasons for atherogenesis in uremia Proc Clin Dial Transplant Forum 7 1977 178 180
30. den Heijer M. H.J. Blom W.B. Gerrits Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet 345 1995 882 885
31. den Heijer M. T. Koster H.J. Blom Hyperhomocysteinemia as a risk factor for deep-vein thrombosis [see comments] N Engl J Med 334 1996 759 762
32. den Heijer M. F.R. Rosendaal H.J. Blom Hyperhomocysteinemia and venous thrombosis: A meta-analysis Thromb Haemos 80 1998 874 877
33. V.W. Dennis K. Robinson Homocysteinemia and vascular disease in end-stage renal disease Kidney Int Suppl 57 1996 S11 S17
34. J. Dierkes M. Kroesen K. Pietrzik Folic acid and vitamin B6 supplementation and plasma homocysteine concentrations in healthy young women Int J Vitam Nutr Res 68 1998 98 103
35. J. Dierkes S. Westphal C. Luley Serum homocysteine increases after therapy with fenofibrate or bezafibrate [letter] Lancet 354 1999 219 220
36. Di Minno G. G. Daví M. Margaglione Abnormally high thromboxane biosynthesis in homozygous homocystinuria: Evidence for platelet involvement and probucol-sensitive mechanism J Clin Invest 92 1993 1400 1406
37. N.P. Dudman S.E. Temple X.W. Guo Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo Circ Res 84 1999 409 416
38. N.P. Dudman D.E. Wilcken J. Wang Disordered methionine/homocysteine metabolism in premature vascular disease: Its occurrence, cofactor therapy, and enzymology Arterioscler Thromb 13 1993 1253 1260
39. R.W. Evans B.J. Shaten J.D. Hempel Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial Arterioscler Thromb Vasc Biol 17 1997 1947 1953
40. M. Fodinger C. Mannhalter G. Wolfl Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients Kidney Int 52 1997 517 523
41. A.R. Folsom F.J. Nieto P.G. McGovern Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: The Atherosclerosis Risk in Communities (ARIC) study [see comments] Circulation 98 1998 204 210
42. P. Frosst H.J. Blom R. Milos A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase [letter] Nat Genet 10 1995 111 113
43. R.H. Fryer B.D. Wilson D.B. Gubler Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells Arterioscler Thromb 13 1993 1327 1333
44. T. Gerritsen J.G. Vaughn H.A. Waisman The identification of homocystine in the urine Biochem Biophys Res Commun 9 1962 493 496
45. E.J. Giltay E.K. Hoogeveen J.M. Elbers Effects of sex steroids on plasma total homocysteine levels: A study in transsexual males and females J Clin Endocrinol Metab 83 1998 550 553
46. D. Girelli S. Friso E. Trabetti Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: Evidence for an important genetic-environmental interaction Blood 91 1998 4158 4163
47. S. Giri P.D. Thompson P. Taxel Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men Atherosclerosis 137 1998 359 366
48. J.E. Graeber J.H. Slott R.E. Ulane Effect of homocysteine and homocystine on platelet and vascular arachidonic acid metabolism Pediatr Res 16 1982 490 493
49. I.M. Graham L.E. Daly H.M. Refsum Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project JAMA 277 1997 1775 1781
50. K.A. Hajjar Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor J Clin Invest 91 1993 2873 2879
51. K.A. Hajjar L. Mauri A.T. Jacovina Tissue plasminogen activator binding to the annexin II tail domain: Direct modulation by homocysteine J Biol Chem 273 1998 9987 9993
52. L.A. Harker J.M. Harlan R. Ross Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons Circ Res 53 1983 731 739
53. L.A. Harker R. Ross S.J. Slichter Homocystine-induced arteriosclerosis J Clin Invest 58 1976 731 741
54. L.A. Harker S.J. Slichter C.R. Scott Homocystinemia: Vascular injury and arterial thrombosis N Engl J Med 291 1974 537 543
55. 111indium-labeled platelets in patients with homocystinuria N Engl J Med 307 1982 781 786
56. E.K. Hoogeveen P.J. Kostense A. Jager Serum homocysteine level and protein intake are related to risk of microalbuminuria: The Hoorn Study [see comments] Kidney Int 54 1998 203 209
57. B. Hultberg A. Andersson A. Isaksson Metabolism of homocysteine, its relation to the other cellular thiols and its mechanism of cell damage in a cell culture line (human histiocytic cell line U-937) Biochim Biophys Acta 1269 1995 6 12
58. P.F. Jacques A.G. Bostom R.R. Williams Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations [see comments] Circulation 93 1996 7 9
59. P.F. Jacques J. Selhub A.G. Bostom The effect of folic acid fortification on plasma folate levels and total homocysteine concentrations N Engl J Med 340 1999 1449 1454
60. S.S. Kang J. Zhou P.W. Wong Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase Am J Hum Genet 43 1988 414 421
61. H.G. Koch M. Goebeler T. Marquardt The redox status of aminothiols as a clue to homocysteine-induced vascular damage Eur J Pediatr 157 suppl 2 1998 S102 S106
62. F.J. Kok J. Schrijver A. Hofman Low vitamin B6 status in patients with acute myocardial infarction Am J Cardiol 63 1989 513 516
63. J.P. Kraus Biochemistry and molecular genetics of cystathionine β-synthase deficiency Eur J Pediatr 157 suppl 2 1998 S50 S53
64. L. Laster S.H. Mudd J.D. Finkelstein Homocystinuria due to cystathionine synthase deficiency: The metabolism of L-methionine J Clin Invest 44 1965 1708 1719
65. S.R. Lentz Homocysteine and vascular dysfunction Life Sci 61 1997 1205 1215
66. S.R. Lentz J.E. Sadler Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine J Clin Invest 88 1991 1906 1914
67. S.R. Lentz J.E. Sadler Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum Blood 81 1993 683 689
68. S.R. Lentz C.G. Sobey D.J. Piegors Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia [see comments] J Clin Invest 98 1996 24 29
69. A. Lobo A. Naso K. Arheart Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12 Am J Cardiol 83 1999 821 825
70. Lowering blood homocysteine with folic acid based supplements Meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration BMJ 316 1998 894 898
71. A. Majors L.A. Ehrhart E.H. Pezacka Homocysteine as a risk factor for vascular disease: Enhanced collagen production and accumulation by smooth muscle cells Arterioscler Thromb Vasc Biol 17 1997 2074 2081
72. M.R. Malinow A.G. Bostom R.M. Krauss Homocyst(e)ine, diet, and cardiovascular diseases: A statement for healthcare professionals from the Nutrition Committee, American Heart Association Circulation 99 1999 178 182
73. M.R. Malinow P.B. Duell D.L. Hess Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease [see comments] N Engl J Med 338 1998 1009 1015
74. M.R. Malinow S.S. Kang L.M. Taylor Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease Circulation 79 1989 1180 1188
75. Z.A. Massy B. Chadefaux-Vekemans A. Chevalier Hyperhomocysteinaemia: A significant risk factor for cardiovascular disease in renal transplant recipients Nephrol Dial Transplant 9 1994 1103 1108
76. E.L. Mayer D.W. Jacobsen K. Robinson Homocysteine and coronary atherosclerosis J Am Coll Cardiol 27 1996 517 527
77. K.S. McCully Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis Am J Pathol 56 1969 111 128
78. V. Mijatovic P. Kenemans C. Jakobs A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women Obstet Gynecol 91 1998 432 436
79. V. Mijatovic P. Kenemans C. Netelenbos Postmenopausal oral 17beta-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels Fertil Steril 69 1998 876 882
80. V. Mijatovic C. Netelenbos van der Mooren M.J. Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women Fertil Steril 70 1998 1085 1089
81. J.W. Miller B. Shukitt-Hale R. Villalobos-Molina Effect of l -dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats Clin Neuropharmacol 20 1997 55 66
82. H.I. Morrison D. Schaubel M. Desmeules Serum folate and risk of fatal coronary heart disease [see comments] JAMA 275 1996 1893 1896
83. A. Moustapha A. Gupta K. Robinson Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis Kidney International 55 1999 1470 1475
84. A. Moustapha A. Naso M. Nahlawi Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease [published erratum appears in Circulation 1998 Feb 24;97(7):711] Circulation 97 1998 138 141
85. S.H. Mudd H.L. Levy F. Skovby Disorders of transsulfuration Scriver C.R. Beaudet A.L. Sly W.S. The Metabolic Basis of Inherited Disease ed 7 1995 McGraw-Hill New York 1279 1327
86. M. Nahlawi A. Naso N. Boparai Low vitamin B6: An independent predictor of cardiovascular morbidity and mortality in heart transplant recipients Circulation 98 suppl I 1998 690
87. Nappo F. De Rosa N. R. Marfella Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins JAMA 281 1999 2113 2118
88. B.G. Nedrebo U.B. Ericsson O. Nygard Plasma total homocysteine levels in hyperthyroid and hypothyroid patients Metabolism 47 1998 89 93
89. O. Nygard J.E. Nordrehaug H. Refsum Plasma homocysteine levels and mortality in patients with coronary artery disease N Engl J Med 337 1997 230 236
90. O. Nygard H. Refsum P.M. Ueland Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine Study Am J Clin Nutr 67 1998 263 270
91. N. Pancharuniti C.A. Lewis H.E. Sauberlich Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease [published erratum appears in Am J Clin Nutr 1996 Apr;63(4):609] Am J Clin Nutr 59 1994 940 948
92. I.J. Perry H. Refsum R.W. Morris Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men Lancet 346 1995 1395 1398
93. J.C. Peterson J.D. Spence Vitamins and progression of atherosclerosis in hyperhomocyst(e)inaemia [letter] Lancet 351 1998 263
94. M. Petri R. Roubenoff G.E. Dallal Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus Lancet 348 1996 1120 1124
95. R. Poddar N. Sivasubramanian K. Robinson Homocysteine modulates the expression of a specific cytokine (monocyte chemoattractant protein 1) in human aortic endothelial cells [abstr] Circulation 96 1997 I 286
96. J. Ray Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease Arch Intern Med 158 1998 2101 2106
97. H. Refsum P.M. Ueland O. Nygard Homocysteine and cardiovascular disease Annu Rev Med 49 1998 31 62
98. P.M. Ridker C.H. Hennekens J. Selhub Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism Circulation 95 1997 1777 1782
99. E.B. Rimm W.C. Willett F.B. Hu Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women [see comments] JAMA 279 1998 359 364
100. J.F. Rinehart L.D. Greenberg Arteriosclerotic lesions in pyridoxine-deficient monkeys Am J Pathol 25 1949 481 491
101. K. Robinson K. Arheart H. Refsum Low circulating folate and vitamin B6 concentrations: Risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group [see comments] Circulation 97 1998 437 443
102. K. Robinson E.L. Mayer D.P. Miller Hyperhomocysteinemia and low pyridoxal phosphate: Common and independent reversible risk factors for coronary artery disease Circulation 92 1995 2825 2830
103. G.M. Rodgers M.T. Conn Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells Blood 75 1990 895 901
104. G.M. Rodgers W.H. Kane Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator J Clin Invest 77 1986 1909 1916
105. J.S. Stamler J.A. Osborne O. Jaraki Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen J Clin Invest 91 1993 308 318
106. J.S. Stamler A. Slivka Biological chemistry of thiols in the vasculature and in vascular-related disease Nutr Rev 54 1 pt 1 1996 1 30
107. M.J. Stampfer M.R. Malinow W.C. Willett A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians JAMA 268 1992 877 881
108. L. Tang C.D. Mamotte Van Bockxmeer F.M. The effect of homocysteine on DNA synthesis in cultured human vascular smooth muscle Atherosclerosis 136 1998 169 173
109. A. Tawakol T. Omland M. Gerhard Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans Circulation 95 1997 1119 1121
110. Taylor L.M. Jr G.L. Moneta G.J. Sexton Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease J Vasc Surg 29 1999 8 21
111. S. Tonstad J. Knudtzon M. Sivertsen Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia J Pediatr 129 1996 42 49
112. J.C. Tsai M.A. Perrella M. Yoshizumi Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis Proc Nat Acad Sci U S A 91 1994 6369 6373
113. K.L. Tucker B. Mahnken P.W. Wilson Folic acid fortification of the food supply: Potential benefits and risks for the elderly population [published erratum appears in JAMA 1997 Mar 5;277(9):714] JAMA 276 1996 1879 1885
114. Ubbink J.B. van der Merwe A. R. Delport The effect of a subnormal vitamin B-6 status on homocysteine metabolism [see comments] J Clin Invest 98 1996 177 184
115. J.B. Ubbink W.J. Vermaak van der Merwe A. Vitamin requirements for the treatment of hyperhomocysteinemia in humans J Nutr 124 1994 1927 1933
116. P.M. Ueland M.A. Mansoor A.B. Guttormsen Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status—a possible element of the extracellular antioxidant defense system J Nutr 126 4 suppl 1996 1281S 1284S
117. E.R. Uhlemann J.H. TenPas A.W. Lucky Platelet survival and morphology in homocystinuria due to cystathionine synthase deficiency N Engl J Med 295 1976 1283 1286
118. Upchurch G.R. Jr G.N. Welch A.J. Fabian Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase J Biol Chem 272 1997 17012 17017
119. van der Griend R. F.J. Haas M. Duran Methionine loading test is necessary for detection of hyperhomocysteinemia J Lab Clin Med 132 1998 67 72
120. van Guldener C. A.J. Donker C. Jakobs No net renal extraction of homocysteine in fasting humans Kidney Int 54 1998 166 169
121. M.C. Verhaar R.M. Wever J.J. Kastelein 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia Circulation 97 1998 237 241
122. P. Verhoef C.H. Hennekens R.H. Allen Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery Am J Cardiol 79 1997 799 801
123. P. Verhoef C.H. Hennekens M.R. Malinow A prospective study of plasma homocyst(e)ine and risk of ischemic stroke Stroke 25 1994 1924 1930
124. R.T. Wall J.M. Harlan L.A. Harker Homocysteine-induced endothelial cell injury in vitro: A model for the study of vascular injury Thromb Res 18 1980 113 121
125. M. Ward H. McNulty J. McPartlin Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid QJM 90 1997 519 524
126. I. Weisberg P. Tran B. Christensen A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity Mol Genet Metab 64 1998 169 172
127. D.E. Wilcken V.J. Gupta Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide Eur J Clin Invest 9 1979 301 307
128. D.E. Wilcken V.J. Gupta A.K. Betts Homocysteine in the plasma of renal transplant recipients: Effects of cofactors for methionine metabolism Clin Sci 61 1981 743 749
129. D.E. Wilcken S.G. Reddy V.J. Gupta Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria Metabolism 32 1983 363 370
130. D.E. Wilcken B. Wilcken The pathogenesis of coronary artery disease: A possible role for methionine metabolism J Clin Invest 57 1976 1079 1082
131. F. Wollesen L. Brattström H. Refsum Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus Kidney Int 55 1999 1028 1035
132. K. Woo P. Chook Y. Lolin Folic acid supplementation improves arterial endothelial function in hyperhomocysteinemic subjects Circulation 96 1997 165
133. K.S. Woo P. Chook Y.I. Lolin Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans Circulation 96 1997 2542 2544
134. K.K. Wu P. Thiagarajan Role of endothelium in thrombosis and hemostasis Annu Rev Med 47 1996 315 331